How Does Stage Affect Mesothelioma Survival?

The Four Stages of Mesothelioma

Pleural mesothelioma is staged using the TNM system, which evaluates tumor extent (T), lymph node involvement (N), and distant metastasis (M). Stage I represents localized disease confined to one side of the chest lining, while stage IV indicates the cancer has spread to distant organs or the opposite side of the body.

Staging is determined through a combination of imaging studies (CT scans, PET scans, MRI) and sometimes surgical exploration. Accurate staging is critical because it directly influences treatment decisions and the range of options available to the patient.

Survival by Stage

Stage I patients have the most favorable prognosis, with median survival times of approximately 21 months or longer. These patients are the best candidates for curative-intent surgery, such as extrapleural pneumonectomy or pleurectomy/decortication, which can significantly extend life when combined with chemotherapy.

Stage II and III patients have intermediate prognoses. Some stage II and select stage III patients may still be eligible for surgery, while others are treated primarily with chemotherapy and immunotherapy. Stage IV patients typically receive palliative treatment aimed at controlling symptoms and maintaining quality of life, with a median survival of 6 to 12 months.

The Importance of Early Detection

Because stage has such a profound impact on survival, early detection is critical. Individuals with a history of asbestos exposure should discuss screening options with their physician. Some medical centers offer surveillance programs for high-risk individuals that may catch mesothelioma at an earlier, more treatable stage.

If you or a loved one has been diagnosed at any stage, pursuing legal compensation can provide resources for treatment and support. An experienced mesothelioma attorney can help you understand your options and act within the applicable time limits.